Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul Chapman
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
- Mount Sinai Medical Center
Miami Beach, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Emory University/winship Cancer Institute
Atlanta, Georgia, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Wayne State University/karmanos Cancer Institute
Detroit, Michigan, United States
- Fairview Ridges Hospital
Burnsville, Minnesota, United States
- Mercy Hospital
Coon Rapids, Minnesota, United States
- Fairview-Southdale Hospital
Edina, Minnesota, United States
- Unity Hospital
Fridley, Minnesota, United States
- Hutchinson Area Health Care
Hutchinson, Minnesota, United States
- Minnesota Oncology Hematology Pa-Maplewood
Maplewood, Minnesota, United States
- Saint John'S Hospital - Healtheast
Maplewood, Minnesota, United States
- Abbott-Northwestern Hospital
Minneapolis, Minnesota, United States
- Hennepin County Medical Center
Minneapolis, Minnesota, United States
- North Memorial Medical Health Center
Robbinsdale, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Metro Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, United States
- Park Nicollet Clinic - Saint Louis Park
Saint Louis Park, Minnesota, United States
- Regions Hospital
Saint Paul, Minnesota, United States
- United Hospital
Saint Paul, Minnesota, United States
- Saint Francis Regional Medical Center
Shakopee, Minnesota, United States
- Ridgeview Medical Center
Waconia, Minnesota, United States
- Minnesota Oncology and Hematology Pa-Woodbury
Woodbury, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
- Vanderbilt University/ingram Cancer Center
Nashville, Tennessee, United States
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
- Wisconsin Clinical Cancer Center
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2010
- Primary completion
- 31 May 2016
- Completion
- 31 May 2016
- Last update posted
- 26 Jul 2017
- Registered enrollment
- 120
- Registry id
- NCT01143402
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.